Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study. - Concepedia

Concepedia

Publication | Closed Access

Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.

273

Citations

0

References

1997

Year

G Omura, J A Blessing, Luis Vaccarello, M L Berman, Daniel L. Clarke‐Pearson, David G. Mutch, Blaire Anderson

Journal of Clinical Oncology

Abstract

CIFX improved the response rate and PFS duration in advanced cervix cancer compared with cisplatin alone, but at the cost of greater toxicity and with no improvement in survival.